CFO
TECH icon

Callan Family Office’s Bio-Techne TECH Stock Holding History

Callan Family Office’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.07M Buy
20,483
+4,143
+25% +$249K 0.02% 543
2025
Q4 		$961K Buy
16,340
+12,448
+320% +$756K 0.02% 559
2025
Q3 		$217K Buy
+3,892
New +$208K 0.01% 804

Other funds holding TECH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Callan Family Office's TECH Position: Q1 2026 in Review

Callan Family Office increased its Bio-Techne (TECH) stake by 25% in Q1 2026, buying an estimated $249K and bringing the position to 20,483 shares worth $1.07M. The position accounts for 0.02% of the portfolio, ranked #543.

Callan Family Office first reported a position in TECH in Q3 2025 and has held it in 3 quarters since. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Callan Family Office held 20,483 shares of Bio-Techne worth $1.07M as of Q1 2026.
  • Callan Family Office bought 4,143 Bio-Techne shares in Q1 2026, an estimated $249K.
  • Bio-Techne made up 0.02% of Callan Family Office's portfolio in Q1 2026, its #543 holding.
  • Callan Family Office first reported a position in Bio-Techne in Q3 2025 and has held it in 3 quarters since.
  • 582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.